KBC Group NV Has $11.44 Million Stake in Axon Enterprise, Inc $AXON

KBC Group NV reduced its position in Axon Enterprise, Inc (NASDAQ:AXONFree Report) by 55.1% during the first quarter, HoldingsChannel reports. The firm owned 26,945 shares of the biotechnology company’s stock after selling 33,002 shares during the period. KBC Group NV’s holdings in Axon Enterprise were worth $11,444,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. Creative Financial Designs Inc. ADV bought a new position in Axon Enterprise during the fourth quarter worth $28,000. Sound Income Strategies LLC boosted its position in Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares during the last quarter. Camelot Portfolios LLC bought a new stake in Axon Enterprise during the fourth quarter valued at $30,000. AlphaCentric Advisors LLC acquired a new stake in Axon Enterprise during the 4th quarter worth about $34,000. Finally, Lodestone Wealth Management LLC acquired a new stake in Axon Enterprise during the 4th quarter worth about $35,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 7th. The stock was sold at an average price of $643.79, for a total transaction of $6,437,900.00. Following the transaction, the chief executive officer directly owned 3,040,997 shares of the company’s stock, valued at $1,957,763,458.63. This represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the stock in a transaction on Friday, June 5th. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the transaction, the president owned 169,125 shares in the company, valued at approximately $82,609,106.25. This represents a 7.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 58,989 shares of company stock valued at $30,527,983. Company insiders own 4.20% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. UBS Group dropped their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Citizens Jmp restated a “market outperform” rating and set a $700.00 price target on shares of Axon Enterprise in a report on Thursday, June 25th. Finally, Morgan Stanley set a $600.00 price objective on shares of Axon Enterprise in a research report on Thursday, May 7th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $725.25.

Check Out Our Latest Report on AXON

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

Axon Enterprise Price Performance

AXON stock opened at $491.49 on Thursday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The company’s 50-day moving average is $478.98 and its 200-day moving average is $479.94. The stock has a market capitalization of $39.61 billion, a PE ratio of 197.39, a price-to-earnings-growth ratio of 10.43 and a beta of 1.38. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $885.91.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The business had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.90 million. During the same period in the previous year, the company posted $1.47 EPS. The firm’s revenue was up 33.7% compared to the same quarter last year. Equities research analysts expect that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Read More

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.